CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
4 Value Stocks Every Investor Should Hold in Volatile Times
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.
Value Investing: 5 Undervalued Stocks Worth Adding to Your Portfolio
StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects.
Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Health: Health Insurers Get Buffett's Stamp Of Approval (Rating Upgrade)
Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the sector's business model remains intact despite recent headwinds. CVS has emerged as a top performer in 2025, with strong revenue growth and raised guidance, outpacing struggling peers like UnitedHealth. The sector faces ongoing uncertainties—rising costs, regulatory scrutiny, and budget cuts—but long-term healthcare spending trends remain favorable.
CVS Advances Digital Efforts to Simplify Healthcare Experience
CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.
Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?
CVS appears well-poised on strong Q2 revenue growth, raised full-year guidance and momentum in key healthcare segments.
5 Low Price-to-Book Stocks to Add to Your Portfolio in August
STNE, CVS, KT, KB and USNA stand out in August for low P/B ratios and strong growth forecasts, making them value stock contenders.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.
